Keros Therapeutics, Inc. KROS
Regular-session close
After hours · Nov 20, 4:01 PM ET
- YTD
- -45.58%
- 1 year
- -34.13%
Held by funds
71 US ETFs and mutual funds hold KROS · largest positions
- NJM 0.01% of fund $7.39M
- IWM 0.01% of fund $5.45M
- VTI 0.00% of fund $5.18M
- BDSKX 0.10% of fund $5.12M
- VSTCX 0.09% of fund $2.95M
- NAJ 0.02% of fund $2.57M
- VXF 0.00% of fund $2.51M
- IWN 0.01% of fund $1.99M
- FSSNX 0.01% of fund $1.98M
- VEXRX 0.01% of fund $1.95M
- DFSV 0.01% of fund $1.85M
- IBB 0.02% of fund $1.61M
- SMLF 0.03% of fund $1.24M
- VTWO 0.01% of fund $1.20M
- SCHA 0.01% of fund $1.16M
- BSVO 0.05% of fund $1.13M
- FSMAX 0.00% of fund $1.07M
- DFAS 0.00% of fund $723.50K
- IWC 0.06% of fund $633.90K
- PRFZ 0.02% of fund $621.31K
Ownership
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| FMR, LLC | 12.09% | 4,899,134 | 83.87M | Sep 29, 2024 |
| Blackrock Inc. | 6.50% | 2,632,608 | 45.07M | Sep 29, 2024 |
| Alkeon Capital Management LLC | 4.68% | 1,897,601 | 32.49M | Sep 29, 2024 |
| Vanguard Group Inc | 4.58% | 1,856,418 | 31.78M | Sep 29, 2024 |
| Darwin Global Management, Ltd. | 3.76% | 1,523,732 | 26.09M | Sep 29, 2024 |
| Price (T.Rowe) Associates Inc | 3.74% | 1,514,505 | 25.93M | Sep 29, 2024 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.37% | 961,347 | 16.46M | Sep 29, 2024 |
| ACAP Strategic Fund | 2.31% | 933,991 | 15.99M | Sep 29, 2024 |
| Price (T.Rowe) New Horizons Fund | 2.17% | 877,880 | 15.03M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 1.87% | 756,550 | 12.95M | Oct 30, 2024 |
| Fidelity Select Portfolios - Biotechnology | 1.63% | 661,229 | 11.32M | Oct 30, 2024 |
| Fidelity Select Portfolios - Health Care | 1.60% | 650,000 | 11.13M | Oct 30, 2024 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Leadership team
Who runs KROS, and what each was last paid
Jasbir S. Seehra, President, Chief Executive Officer & DirectorAverage age 54
| Name | Title | Pay | Age |
|---|---|---|---|
| Jasbir S. Seehra | President, Chief Executive Officer & Director | $1.11M | 70 |
| Esther Cho | Chief Legal Officer & Secretary | $634K | 37 |
| Lorena Lerner | Chief Scientific Officer | — | 54 |
| Justin Frantz | Head of Investor Relations | — | — |
| Annita Tanini | VP of Finance, Corporate Controller and Interim Principal Financial & Accounting Officer | — | 55 |
Pay is the latest total FMP has for each person (salary, bonus, stock and other awards) and can lag the newest proxy statement. Source: Financial Modeling Prep, from the company’s SEC filings.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| GORDON CARL L | Director | Sale | Aug 12, 2024 | 0 |
| ORBIMED ADVISORS, L.L.C. | Unknown | Sale | Aug 12, 2024 | 0 |
| REGNANTE KEITH C | Chief Financial Officer | Conversion of Exercise of derivative security | Nov 2, 2023 | 0 |
| SEEHRA JASBIR | Chief Executive Officer | Conversion of Exercise of derivative security | Apr 6, 2023 | 252,856 |
